Nicotinamide mononucleotide adenylyltransferase is not only a key enzyme in the biosynthesis of NAD+, but is also closely related to the activation of SIRTs and has been shown to inhibit angiotensin II-induced cardiac hypertrophy [86]. The gene discussed is AGT; the disease is cardiac hypertrophy.